1. Smad3‐mediated recruitment of the methyltransferase SETDB1/ESET controls Snail1 expression and epithelial–mesenchymal transition
   Dan Du et al, 2018, EMBO reports CrossRef
2. Stabilization of MOF (KAT8) by USP10 promotes esophageal squamous cell carcinoma proliferation and metastasis through epigenetic activation of ANXA2/Wnt signaling
   Peichao Li et al, 2024, Oncogene CrossRef
3. In Silico Evaluation of Natural Compounds for an Acidic Extracellular Environment in Human Breast Cancer
   YoungJoon Park et al, 2021, Cells CrossRef
4. Protein Profiling in Human Papillomavirus-Associated Cervical Carcinogenesis: Cornulin as a Biomarker for Disease Progression
   Gaayathri Kumarasamy et al, 2023, Current Issues in Molecular Biology CrossRef
5. Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment
   Li-Wei Qiu et al, 2020, World Journal of Gastroenterology CrossRef
6. Comprehensive analysis the diagnosis, malignant progression and immune infiltrate of ANXA6 in prostate cancer
   Banggao Huang et al, 2023, Genes & Genomics CrossRef
7. (20S)G-Rh2 Inhibits NF-κB Regulated Epithelial-Mesenchymal Transition by Targeting Annexin A2
   Yu-Shi Wang et al, 2020, Biomolecules CrossRef
8. Biomarkers of tumor invasiveness in proteomics (Review)
   Daniel Pouliquen et al, 2020, International Journal of Oncology CrossRef
9. ASIC1a contributes to the epithelial–mesenchymal transformation of breast cancer by activating the Ca2+/β‐catenin pathway
   Jiawei Wang et al, 2024, Environmental Toxicology CrossRef
10. ANXA2 Silencing Inhibits Proliferation, Invasion, and Migration in Gastric Cancer Cells
    Rui Xie et al, 2019, Journal of Oncology CrossRef
11. Annexin A2: The diversity of pathological effects in tumorigenesis and immune response
    Yanjie Huang et al, 2022, International Journal of Cancer CrossRef
12. Characterization of exosomes in peritoneal fluid of endometriosis patients
    Hannah M. Nazri et al, 2020, Fertility and Sterility CrossRef
13. Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies
    Victoria M. Kim et al, 2019, Journal for ImmunoTherapy of Cancer CrossRef
14. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins
    Rui Gou et al, 2019, Journal of Translational Medicine CrossRef
15. MicroRNA-342 Promotes the Malignant-Like Phenotype of Endometrial Stromal Cells via Regulation of Annexin A2
    Dan Sun et al, 2021, Analytical Cellular Pathology CrossRef
16. Transcriptome‐level discovery of survival‐associated biomarkers and therapy targets in non‐small‐cell lung cancer
    Balázs Győrffy, 2024, British Journal of Pharmacology CrossRef
17. Study on the inhibition of dexmedetomidine (DEX) on malignant development of breast cancer by synchrotron radiation infrared spectroscopy
    Chao YANG et al, 2023, Chinese Journal of Analytical Chemistry CrossRef